Cargando…
lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis
INTRODUCTION: Our work was aimed to explore the mechanisms of MAGI2 antisense RNA 3 (MAGI2-AS3) in regulating hepatocellular carcinoma (HCC) carcinogenesis. METHODS: MAGI2-AS3, microRNA-519c-3p (miR-519c-3p), and thioredoxin interacting protein (TXNIP) levels in HCC were detected by the RT-qPCR meth...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416383/ https://www.ncbi.nlm.nih.gov/pubmed/34484334 http://dx.doi.org/10.1155/2021/5547345 |
_version_ | 1783748168631975936 |
---|---|
author | Wei, Huamei Tang, Qianli Wang, Anmin Zhang, Ya Qin, Zebang Li, Wenchuan Xu, Zuoming Wang, Jianchu Pu, Jian |
author_facet | Wei, Huamei Tang, Qianli Wang, Anmin Zhang, Ya Qin, Zebang Li, Wenchuan Xu, Zuoming Wang, Jianchu Pu, Jian |
author_sort | Wei, Huamei |
collection | PubMed |
description | INTRODUCTION: Our work was aimed to explore the mechanisms of MAGI2 antisense RNA 3 (MAGI2-AS3) in regulating hepatocellular carcinoma (HCC) carcinogenesis. METHODS: MAGI2-AS3, microRNA-519c-3p (miR-519c-3p), and thioredoxin interacting protein (TXNIP) levels in HCC were detected by the RT-qPCR method. Cell proliferation and apoptosis rate were measured using Cell Counting Kit-8 assay and flow cytometry assay. Relationship between MAGI2-AS3, TXNIP, and miR-519c-3p were analyzed via luciferase activity assay, RNA pull-down assay, and RNA immunoprecipitation assay. Mouse xenograft models of HCC were conducted to explore the roles of MAGI2-AS3 in vivo. RESULTS: MAGI2-AS3 levels were elevated, and miR-519c-3p decreased in HCC. MAGI2-AS3 overexpression inhibits while its knockdown stimulates HCC cell growth through miR-519c-3p. Moreover, miR-519c-3p overexpression stimulates HCC cell growth. MAGI2-AS3 serves as competing endogenous RNA (ceRNA) of miR-519c-3p to regulate TXNIP in HCC. And, TXNIP upregulation weakened the influence of MAGI2-AS3 knockdown on HCC cell behaviors. Additionally, MAGI2-AS3 overexpression suppressed HCC tumor growth in vivo. CONCLUSION: MAGI2-AS3 inhibits HCC tumorigenesis through miR-519c-3p/TXNIP axis in vitro and in vivo, indicating MAGI2-AS3 plays a crucial role in HCC development. |
format | Online Article Text |
id | pubmed-8416383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-84163832021-09-04 lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis Wei, Huamei Tang, Qianli Wang, Anmin Zhang, Ya Qin, Zebang Li, Wenchuan Xu, Zuoming Wang, Jianchu Pu, Jian J Oncol Research Article INTRODUCTION: Our work was aimed to explore the mechanisms of MAGI2 antisense RNA 3 (MAGI2-AS3) in regulating hepatocellular carcinoma (HCC) carcinogenesis. METHODS: MAGI2-AS3, microRNA-519c-3p (miR-519c-3p), and thioredoxin interacting protein (TXNIP) levels in HCC were detected by the RT-qPCR method. Cell proliferation and apoptosis rate were measured using Cell Counting Kit-8 assay and flow cytometry assay. Relationship between MAGI2-AS3, TXNIP, and miR-519c-3p were analyzed via luciferase activity assay, RNA pull-down assay, and RNA immunoprecipitation assay. Mouse xenograft models of HCC were conducted to explore the roles of MAGI2-AS3 in vivo. RESULTS: MAGI2-AS3 levels were elevated, and miR-519c-3p decreased in HCC. MAGI2-AS3 overexpression inhibits while its knockdown stimulates HCC cell growth through miR-519c-3p. Moreover, miR-519c-3p overexpression stimulates HCC cell growth. MAGI2-AS3 serves as competing endogenous RNA (ceRNA) of miR-519c-3p to regulate TXNIP in HCC. And, TXNIP upregulation weakened the influence of MAGI2-AS3 knockdown on HCC cell behaviors. Additionally, MAGI2-AS3 overexpression suppressed HCC tumor growth in vivo. CONCLUSION: MAGI2-AS3 inhibits HCC tumorigenesis through miR-519c-3p/TXNIP axis in vitro and in vivo, indicating MAGI2-AS3 plays a crucial role in HCC development. Hindawi 2021-08-27 /pmc/articles/PMC8416383/ /pubmed/34484334 http://dx.doi.org/10.1155/2021/5547345 Text en Copyright © 2021 Huamei Wei et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wei, Huamei Tang, Qianli Wang, Anmin Zhang, Ya Qin, Zebang Li, Wenchuan Xu, Zuoming Wang, Jianchu Pu, Jian lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis |
title | lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis |
title_full | lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis |
title_fullStr | lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis |
title_full_unstemmed | lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis |
title_short | lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis |
title_sort | lncrna magi2-as3 exerts antioncogenic roles in hepatocellular carcinoma via regulating the mir-519c-3p/txnip axis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416383/ https://www.ncbi.nlm.nih.gov/pubmed/34484334 http://dx.doi.org/10.1155/2021/5547345 |
work_keys_str_mv | AT weihuamei lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis AT tangqianli lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis AT wanganmin lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis AT zhangya lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis AT qinzebang lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis AT liwenchuan lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis AT xuzuoming lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis AT wangjianchu lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis AT pujian lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis |